Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 4Withdrawn 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Kidney Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 1Prostatic Neoplasms 1Pain 1Neoplasm Metastasis 1Mesothelioma 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1Bone Neoplasms 1Adenocarcinoma 1

Interventions

Oxaliplatin 20Fluorouracil 20Leucovorin 19Bevacizumab 16Cetuximab 13Irinotecan 12Capecitabine 8regorafenib 5Radiotherapy 5Nivolumab 5Drug Therapy 5aflibercept 4Radiosurgery 4Neoadjuvant Therapy 4Magnetic Resonance Spectroscopy 4Chemotherapy, Adjuvant 4Biopsy 4pembrolizumab 3durvalumab 3atezolizumab 3Specimen Handling 3Folfox protocol 3Cyclophosphamide 3trifluridine tipiracil drug combination 2tremelimumab 2tislelizumab 2poly(I).poly(c12,U) 2futuximab 2fludarabine 2avelumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Colorectal Neoplasms × Cryosurgery × Clear all
NCT01741038 2020-01-22

AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer

Mirror Biologics, Inc.

Phase 2/3 Withdrawn
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡